Among the hot topics dominating the buzz at the J.P. Morgan Healthcare Conference earlier this year, high on the list were the profound changes impacting generics and specialty pharma. At the conference, I spoke with executives from companies across each of these industry segments and discussed the unique challenges affecting their business. During these conversations, each executive had one common ...

The rising costs of prescription drugs and healthcare delivery is impacting the way the pharmaceutical industry brings new medicines to market. Today, key healthcare stakeholders from the, payer, provider, accountable care organization (ACO), pharmacy benefit manager (PBM), and patient communities are playing an increased role in determining the market access strategies for new drugs.   Concerned with a myriad of ...